mesalamine has been researched along with colchicine in 11 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (9.09) | 18.2507 |
| 2000's | 3 (27.27) | 29.6817 |
| 2010's | 7 (63.64) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Lombardo, F; Obach, RS; Waters, NJ | 1 |
| Artursson, P; Bergström, CA; Hoogstraate, J; Matsson, P; Norinder, U; Pedersen, JM | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Cantin, LD; Chen, H; Kenna, JG; Noeske, T; Stahl, S; Walker, CL; Warner, DJ | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Crotty, B; Dalton, HR; Hoang, P; Jewell, DP | 1 |
| Basturk, T; Kusaslan, R; Ozagari, A; Ozturk, T; Unsal, A | 1 |
| Cheon, JH; Chung, MJ; Kim, NK; Kim, SU; Kim, TI; Kim, WH; Park, JJ | 1 |
| Awaji, K; Inokuchi, R; Maehara, H; Moriyama, M; Ohmae, T; Okamoto, M; Suyama, Y | 1 |
| Asano, T; Hashimoto, Y; Kawana, S; Kobayashi, H; Matsuoka, N; Migita, K; Sato, S; Tasaki, K; Watanabe, H; Yashiro, M | 1 |
| Chiang, BL; Hu, YC; Lee, JH; Lin, YT; Wang, LC; Yang, YH; Yu, HH | 1 |
2 review(s) available for mesalamine and colchicine
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Crohn's disease and secondary amyloidosis: early complication? A case report and review of the literature.
Topics: Adult; Amyloidosis; Anti-Inflammatory Agents, Non-Steroidal; Biopsy; Colchicine; Crohn Disease; Disease Progression; Early Diagnosis; Humans; Hypertension; Hypoalbuminemia; Kidney Failure, Chronic; Male; Mesalamine; Proteinuria; Rare Diseases; Renal Dialysis; Risk Factors; Time Factors | 2009 |
9 other study(ies) available for mesalamine and colchicine
| Article | Year |
|---|---|
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Prediction and identification of drug interactions with the human ATP-binding cassette transporter multidrug-resistance associated protein 2 (MRP2; ABCC2).
Topics: Administration, Oral; Animals; Antineoplastic Agents; Antipsychotic Agents; Antiviral Agents; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 1; ATP Binding Cassette Transporter, Subfamily G, Member 2; ATP-Binding Cassette Transporters; Biological Transport; Cell Line; Computer Simulation; Cytochrome P-450 Enzyme System; Drug-Related Side Effects and Adverse Reactions; Estradiol; Humans; Insecta; Liver; Models, Molecular; Multidrug Resistance-Associated Protein 2; Multidrug Resistance-Associated Proteins; Neoplasm Proteins; Pharmaceutical Preparations; Pharmacology; Structure-Activity Relationship | 2008 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Mitigating the inhibition of human bile salt export pump by drugs: opportunities provided by physicochemical property modulation, in silico modeling, and structural modification.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Bile Acids and Salts; Cell Line; Chemical and Drug Induced Liver Injury; Humans; Quantitative Structure-Activity Relationship | 2012 |
Salicylates used in inflammatory bowel disease and colchicine impair interferon-gamma induced HLA-DR expression.
Topics: Aminosalicylic Acid; Aminosalicylic Acids; Cell Line; Colchicine; Colon; Epithelium; Flow Cytometry; HLA-DR Antigens; Humans; Inflammatory Bowel Diseases; Interferon-gamma; Male; Mesalamine; Middle Aged; Salicylates | 1992 |
Response rates to medical treatments and long-term clinical outcomes of nonsurgical patients with intestinal Behçet disease.
Topics: Adolescent; Adrenal Cortex Hormones; Adult; Aged; Anti-Inflammatory Agents, Non-Steroidal; Azathioprine; Behcet Syndrome; Colchicine; Drug Therapy, Combination; Female; Humans; Immunosuppressive Agents; Intestinal Diseases; Korea; Male; Mesalamine; Middle Aged; Prognosis; Recurrence; Risk Factors; Time Factors; Treatment Outcome; Ulcer; Young Adult | 2010 |
Gastrointestinal Behçet's disease: periodic fever, multiple ulcers and trisomy 8 in elderly man.
Topics: Aged; Anti-Inflammatory Agents, Non-Steroidal; Behcet Syndrome; Capsule Endoscopy; Chromosomes, Human, Pair 8; Colchicine; Gastrointestinal Diseases; Gout Suppressants; Humans; Male; Mesalamine; Treatment Outcome; Trisomy; Ulcer | 2018 |
Behçet disease associated with gastrointestinal amyloidosis manifested as hematochezia: A case report.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Behcet Syndrome; Colchicine; Colon; Colonic Diseases; Gastrointestinal Hemorrhage; Glucocorticoids; Humans; Immunoglobulin Light-chain Amyloidosis; Male; Mesalamine; Middle Aged; Prednisolone; Tubulin Modulators; Ulcer | 2018 |
Clinical manifestations and anti-TNF alpha therapy of juvenile Behçet's disease in Taiwan.
Topics: Adalimumab; Adolescent; Antirheumatic Agents; Behcet Syndrome; Child; Colchicine; Drug Therapy, Combination; Etanercept; Female; Follow-Up Studies; Humans; Immunosuppressive Agents; Male; Mesalamine; Prednisolone; Retrospective Studies; Severity of Illness Index; Sulfasalazine; Symptom Assessment; Taiwan; Tertiary Care Centers; Treatment Outcome; Tumor Necrosis Factor-alpha | 2019 |